Dr. LeBoeuf is clinical director for cutaneous oncology and director of the Program in Skin Toxicities for Anticancer Therapy at Dana-Farber Cancer Institute, and is an assistant professor in dermatology at Harvard Medical School. Her clinical interests include cutaneous T and B-cell lymphomas, cutaneous toxicities from anti-cancer therapies, inherited cancer syndromes, melanoma, and rare and advanced skin cancers.

She received her medical degree from the University of Massachusetts and completed a residency in dermatology at Columbia University Medical Center and a fellowship in cutaneous oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. She is board certified in dermatology.